Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. A study on 68 Chinese patients in Taiwan

Hwei Fang Tien, Chiu Hwa Wang, Sou Ming Chuang, Jyh Ming Chow, Fen Yu Lee, Ming Chi Liu, Yao Chang Chen, Ming Ching Shen, Dong Tsam Lin, Kai Hsin Lin

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Cytogenetics and clinical features were studied for 68 Chinese patients with primary myelodysplastic syndrome (MDS). Ras mutation was analyzed in 25 of them. Thirty-four patients (50%) had clonal chromosomal abnormalities at initial analysis. The most common cytogenetic aberrations were -7, +8, 5q-, and 20q-, which occurred in 11 (16.2%), seven (10.3%), five (7.4%) and three patients, respectively. The incidence of -7 was higher and that of 5q- lower in our patients than in patients from most other geographic areas. The 17 patients with multiple chromosomal abnormalities had a significantly shorter median survival (9 months) than the 34 patients with normal karyotype (33 months) and the 17 patients with patients with single anomalies (26 months). Evolution to acute leukemia occurred in 20 patients (29%) after a median interval of 8 months following the diagnosis. Patients with multiple cytogenetic changes at initial analysis or in subsequent studies had a significantly higher frequency of acute transformation than others (55% vs. 18.6%, p = 0.007); the same was not true if only the data of initial study were considered. Serial cytogenetic studies are important in patient follow-up. N-ras mutation was detected in 5 (20%) of 25 patients within the study. There was no correlation between the gene mutation and acute transformation. But combing the data of N-ras mutation and cytogenetics, patients with either the N-ras mutation or clonal chromosomal abnormalities were at significantly higher risk for developing acute leukemia than those with neither of the changes (77% vs. 25%).

Original languageEnglish
Pages (from-to)40-49
Number of pages10
JournalCancer Genetics and Cytogenetics
Volume74
Issue number1
DOIs
Publication statusPublished - 1994
Externally publishedYes

Fingerprint

Myelodysplastic Syndromes
Taiwan
Cytogenetics
Mutation
Chromosome Aberrations
Leukemia
Multiple Abnormalities
Karyotype

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. A study on 68 Chinese patients in Taiwan. / Tien, Hwei Fang; Wang, Chiu Hwa; Chuang, Sou Ming; Chow, Jyh Ming; Lee, Fen Yu; Liu, Ming Chi; Chen, Yao Chang; Shen, Ming Ching; Lin, Dong Tsam; Lin, Kai Hsin.

In: Cancer Genetics and Cytogenetics, Vol. 74, No. 1, 1994, p. 40-49.

Research output: Contribution to journalArticle

Tien, Hwei Fang ; Wang, Chiu Hwa ; Chuang, Sou Ming ; Chow, Jyh Ming ; Lee, Fen Yu ; Liu, Ming Chi ; Chen, Yao Chang ; Shen, Ming Ching ; Lin, Dong Tsam ; Lin, Kai Hsin. / Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. A study on 68 Chinese patients in Taiwan. In: Cancer Genetics and Cytogenetics. 1994 ; Vol. 74, No. 1. pp. 40-49.
@article{3db1d4217ef042369308e59fb81252df,
title = "Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. A study on 68 Chinese patients in Taiwan",
abstract = "Cytogenetics and clinical features were studied for 68 Chinese patients with primary myelodysplastic syndrome (MDS). Ras mutation was analyzed in 25 of them. Thirty-four patients (50{\%}) had clonal chromosomal abnormalities at initial analysis. The most common cytogenetic aberrations were -7, +8, 5q-, and 20q-, which occurred in 11 (16.2{\%}), seven (10.3{\%}), five (7.4{\%}) and three patients, respectively. The incidence of -7 was higher and that of 5q- lower in our patients than in patients from most other geographic areas. The 17 patients with multiple chromosomal abnormalities had a significantly shorter median survival (9 months) than the 34 patients with normal karyotype (33 months) and the 17 patients with patients with single anomalies (26 months). Evolution to acute leukemia occurred in 20 patients (29{\%}) after a median interval of 8 months following the diagnosis. Patients with multiple cytogenetic changes at initial analysis or in subsequent studies had a significantly higher frequency of acute transformation than others (55{\%} vs. 18.6{\%}, p = 0.007); the same was not true if only the data of initial study were considered. Serial cytogenetic studies are important in patient follow-up. N-ras mutation was detected in 5 (20{\%}) of 25 patients within the study. There was no correlation between the gene mutation and acute transformation. But combing the data of N-ras mutation and cytogenetics, patients with either the N-ras mutation or clonal chromosomal abnormalities were at significantly higher risk for developing acute leukemia than those with neither of the changes (77{\%} vs. 25{\%}).",
author = "Tien, {Hwei Fang} and Wang, {Chiu Hwa} and Chuang, {Sou Ming} and Chow, {Jyh Ming} and Lee, {Fen Yu} and Liu, {Ming Chi} and Chen, {Yao Chang} and Shen, {Ming Ching} and Lin, {Dong Tsam} and Lin, {Kai Hsin}",
year = "1994",
doi = "10.1016/0165-4608(94)90027-2",
language = "English",
volume = "74",
pages = "40--49",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. A study on 68 Chinese patients in Taiwan

AU - Tien, Hwei Fang

AU - Wang, Chiu Hwa

AU - Chuang, Sou Ming

AU - Chow, Jyh Ming

AU - Lee, Fen Yu

AU - Liu, Ming Chi

AU - Chen, Yao Chang

AU - Shen, Ming Ching

AU - Lin, Dong Tsam

AU - Lin, Kai Hsin

PY - 1994

Y1 - 1994

N2 - Cytogenetics and clinical features were studied for 68 Chinese patients with primary myelodysplastic syndrome (MDS). Ras mutation was analyzed in 25 of them. Thirty-four patients (50%) had clonal chromosomal abnormalities at initial analysis. The most common cytogenetic aberrations were -7, +8, 5q-, and 20q-, which occurred in 11 (16.2%), seven (10.3%), five (7.4%) and three patients, respectively. The incidence of -7 was higher and that of 5q- lower in our patients than in patients from most other geographic areas. The 17 patients with multiple chromosomal abnormalities had a significantly shorter median survival (9 months) than the 34 patients with normal karyotype (33 months) and the 17 patients with patients with single anomalies (26 months). Evolution to acute leukemia occurred in 20 patients (29%) after a median interval of 8 months following the diagnosis. Patients with multiple cytogenetic changes at initial analysis or in subsequent studies had a significantly higher frequency of acute transformation than others (55% vs. 18.6%, p = 0.007); the same was not true if only the data of initial study were considered. Serial cytogenetic studies are important in patient follow-up. N-ras mutation was detected in 5 (20%) of 25 patients within the study. There was no correlation between the gene mutation and acute transformation. But combing the data of N-ras mutation and cytogenetics, patients with either the N-ras mutation or clonal chromosomal abnormalities were at significantly higher risk for developing acute leukemia than those with neither of the changes (77% vs. 25%).

AB - Cytogenetics and clinical features were studied for 68 Chinese patients with primary myelodysplastic syndrome (MDS). Ras mutation was analyzed in 25 of them. Thirty-four patients (50%) had clonal chromosomal abnormalities at initial analysis. The most common cytogenetic aberrations were -7, +8, 5q-, and 20q-, which occurred in 11 (16.2%), seven (10.3%), five (7.4%) and three patients, respectively. The incidence of -7 was higher and that of 5q- lower in our patients than in patients from most other geographic areas. The 17 patients with multiple chromosomal abnormalities had a significantly shorter median survival (9 months) than the 34 patients with normal karyotype (33 months) and the 17 patients with patients with single anomalies (26 months). Evolution to acute leukemia occurred in 20 patients (29%) after a median interval of 8 months following the diagnosis. Patients with multiple cytogenetic changes at initial analysis or in subsequent studies had a significantly higher frequency of acute transformation than others (55% vs. 18.6%, p = 0.007); the same was not true if only the data of initial study were considered. Serial cytogenetic studies are important in patient follow-up. N-ras mutation was detected in 5 (20%) of 25 patients within the study. There was no correlation between the gene mutation and acute transformation. But combing the data of N-ras mutation and cytogenetics, patients with either the N-ras mutation or clonal chromosomal abnormalities were at significantly higher risk for developing acute leukemia than those with neither of the changes (77% vs. 25%).

UR - http://www.scopus.com/inward/record.url?scp=0028178531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028178531&partnerID=8YFLogxK

U2 - 10.1016/0165-4608(94)90027-2

DO - 10.1016/0165-4608(94)90027-2

M3 - Article

C2 - 8194046

AN - SCOPUS:0028178531

VL - 74

SP - 40

EP - 49

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 1

ER -